Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polymerase (RNA) III (DNA Directed) Polypeptide K, 12.3 kDa pseudogene (ENSG00000274446) is classified as a pseudogene, meaning it is a segment of DNA similar to a known gene (POLR3K) but is typically non-functional due to mutations or lack of regulatory elements required for gene expression. Pseudogenes generally do not produce functional proteins and are not considered targets for drugs or other therapeutic interventions. They may sometimes be transcribed, but their biological significance in most cases is limited or uncertain[1][3]. Summary of findings: - This target is incorrectly described if assumed to be a functional therapeutic target. - It is correctly identified as a pseudogene, which differentiates it from enzymes, receptors, or transporters. - There is no structured information (aliases, molecular classifications, disease roles, etc.) that would apply to active protein targets. If you later need to extract structured data, treat this as a negative/invalid target—this entry cannot be matched to canonical protein target classifications in pharmacology, molecular biology, or drug discovery[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polymerase (RNA) III (DNA Directed) Polypeptide K, 12.3 kDa pseudogene (ENSG00000274446).